| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9825 |
| Human Intestinal Absorption | HIA+ | 0.9972 |
| Caco-2 Permeability | Caco2+ | 0.7859 |
| P-glycoprotein Substrate | Non-substrate | 0.8042 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9547 |
| Non-inhibitor | 0.9694 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9249 |
| Distribution |
| Subcellular localization | Mitochondria | 0.3921 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7608 |
| CYP450 2D6 Substrate | Non-substrate | 0.9374 |
| CYP450 3A4 Substrate | Non-substrate | 0.7832 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8084 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9532 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9760 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9570 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9825 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8948 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9394 |
| Non-inhibitor | 0.9836 |
| AMES Toxicity | AMES toxic | 0.8748 |
| Carcinogens | Carcinogens | 0.6907 |
| Fish Toxicity | High FHMT | 0.6777 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9741 |
| Honey Bee Toxicity | High HBT | 0.8290 |
| Biodegradation | Ready biodegradable | 0.5392 |
| Acute Oral Toxicity | III | 0.7443 |
| Carcinogenicity (Three-class) | Non-required | 0.6069 |